Objective: To determine the prevalence of polycystic ovary syndrome (PCOS)
among hyperandrogenic women who report normal menses.
Design: Prospective observational study.
Setting: Academic practice in reproductive endocrinology.
Patient(s): Fifty-eight consecutively seen new patients with hyperandrogeni
sm who reported normal menses.
Intervention(s): Ovulatory status was assessed with timed serum progesteron
e measurements. The following tests also were carried out: vaginal ultrasou
nd examination; measurement of the ovarian response of 17-hydroxyprogestero
ne (17-OHP) after the administration of leuprolide acetate, 1 mg SC; and de
termination of fasting serum LH, FSH, E-2, 17-OHP, insulin, and androgen le
vels.
Main Outcome Measure(s): Determination of ovulatory status, polycystic appe
arance of ovaries, and increased response of 17-OHP to leuprolide acetate.
Result(s): Twelve (20.7%) of the hyperandrogenic women were anovulatory and
met the usual criteria for the diagnosis of PCOS. The ovulatory patients h
ad lower serum total and unbound testosterone levels. Thirty-one (53.4%) of
the ovulatory women had polycystic ovaries on ultrasound examination and/o
r an increased 17-OHP response to leuprolide acetate, suggesting the diagno
sis of PCOS despite the presence of ovulation. Considering both the anovula
tory and ovulatory patients, 74% of the hyperandrogenic women studied could
have PCOS.
Conclusion(s): The data suggest that most (74%) hyperandrogenic women who r
eport normal menses have evidence for the diagnosis of PCOS. (Fertil Steril
(R) 1999,71:319-22. (C) 1999 by American Society for Reproductive Medicine.
)